Navigation Links
Boehringer Ingelheim and Eli Lilly and Company submit new drug application to FDA for empagliflozin, an investigational type 2 diabetes treatment
Date:3/25/2013

tal protection and sustainability are intrinsic factors in all of Boehringer Ingelheim's endeavors.

In 2011, Boehringer Ingelheim achieved net sales of about $17.1 billion (13.2 billion euro). R&D expenditure in the business area Prescription Medicines corresponds to 23.5% of its net sales.

For more information, please visit http://us.boehringer-ingelheim.com and follow us on Twitter at http://twitter.com/boehringerus.

About Eli Lilly and Company 
Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, IN, Lilly provides answers – through medicines and information – for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com.

About Lilly Diabetes
Lilly has been a global leader in diabetes care since 1923, when we introduced the world's first commercial insulin. Today we work to meet the diverse needs of people with diabetes through research and collaboration, a broad and growing product portfolio and our continued commitment to providing real solutions – from medicines to support programs and more – to make lives better.

For more information, visit www.lillydiabetes.com.

This press release contains forward-looking statements about empagliflozin* for the treatment of type 2 diabetes. It reflects Lilly's current beliefs; however, as with any such undertaking, there are substantial risks and uncertainties in the process of drug development and commercialization. There is no guarantee t
'/>"/>

SOURCE Eli Lilly and Company; Boehringer Ingelheim
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Boehringer Ingelheim Announces Interim Results Evaluating Virologic Response Rates in HCV/HIV Co-Infected Patients Treated with Faldaprevir
2. Boehringer Ingelheim Cares Foundation Launches Online Giving Report
3. Boehringer Ingelheim Presents Efficacy Data for Tiotropium in Symptomatic Asthma Patients in Relation to Allergic Status
4. Pharmaceutical Leader Boehringer Ingelheim Selects Republica as Cross-Cultural Marketing Agency
5. Boehringer Ingelheim Selects ChemAxon to Power Next-Generation Global Cheminformatics Platform
6. FDA Advisory Committee Recommends Approval for Boehringer Ingelheims Olodaterol for Maintenance Treatment of COPD
7. Boehringer Ingelheim and Ashoka Changemakers Launch Competition to Find Business Models that Transform Health Systems
8. Boehringer Ingelheim Enrolls First Patients in Pivotal Phase 3 Interferon-Free Hepatitis C Trial Program
9. Boehringer Ingelheim Presents New Phase II Data for Volasertib in Adult Patients with AML
10. Boehringer Ingelheim Announces Equine Research Awards
11. Phase 2b Data of Boehringer Ingelheims Interferon-Free Hepatitis C Treatment Show Viral Cure Achieved in Up to 85% of Treatment-Naive Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... Ill. , July 7, 2015  Monopar Therapeutics ... oncology compounds, announced that its co-founder and CEO, ... British Council,s Education U.K. Alumni Entrepreneurial Award. The British ... China , India , and ... recognizes outstanding achievements made by entrepreneurs who have leveraged ...
(Date:7/7/2015)... SAN DIEGO , July 7, 2015 /PRNewswire/ ... pharmaceuticals, announced today initiation of enrollment and dosing ... clinical study of ABX-1431, a first-in-class, investigational endocannabinoid ... technology platform, which finds new small molecule drug ... of enzymes with important regulatory roles in human ...
(Date:7/7/2015)... NEW YORK , July 7, 2015  New ... treated with radiation therapy versus surgery for prostate ... University of Toronto presented their findings at the ... last month, which further suggest that prostate ... increased risk of requiring minimally invasive urologic procedures due ...
Breaking Medicine Technology:Monopar Therapeutics Announces Founder And CEO Chandler Robinson Awarded The British Council's Education U.K. Alumni Award 2Monopar Therapeutics Announces Founder And CEO Chandler Robinson Awarded The British Council's Education U.K. Alumni Award 3Abide Therapeutics Announces First Subject Dosed in First-in-Human Clinical Study of ABX-1431, an Investigational Endocannabinoid System Modulator 2Abide Therapeutics Announces First Subject Dosed in First-in-Human Clinical Study of ABX-1431, an Investigational Endocannabinoid System Modulator 3New Study Shows Surgery Has Less Side Effects and Long-Term Issues Over Radiation for Treating Prostate Cancer 2New Study Shows Surgery Has Less Side Effects and Long-Term Issues Over Radiation for Treating Prostate Cancer 3New Study Shows Surgery Has Less Side Effects and Long-Term Issues Over Radiation for Treating Prostate Cancer 4
... /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: ... medical devices worldwide, today announced shareholder resolutions adopted at ... Kong on December 22, 2010. At the ... Ms. Joyce I-Yin Hsu and Mr. Wu Qiyao, each ...
... Inc. (Nasdaq: CEPH ) today announced that ... the U.S. Food and Drug Administration (FDA) for the ... [C-IV] for the treatment of patients with excessive sleepiness ...  In its letter to the company, the FDA reiterated ...
Cached Medicine Technology:Cephalon Receives Complete Response Letter for NUVIGIL for the Treatment of Excessive Sleepiness Associated With Jet Lag Disorder 2Cephalon Receives Complete Response Letter for NUVIGIL for the Treatment of Excessive Sleepiness Associated With Jet Lag Disorder 3
(Date:7/7/2015)... , ... July 07, 2015 , ... Healthpointe ... management team. Dr. Alupay, an anesthesiologist and pain management specialist, will be evaluating and ... well as neurological conditions. , After receiving his Bachelor of Science in Biology from ...
(Date:7/7/2015)... (PRWEB) , ... July 07, 2015 , ... Parents and ... post by A Forever Recovery, an open-ended holistic treatment center for drug and alcohol ... for Drug Use and HIV Research has shown a significant increase in the “club ...
(Date:7/7/2015)... ... 07, 2015 , ... FSAstore.com today announced the launch of its ... makes it simple to use, spend and manage HSA funds with innovative tools including ... , According to a report by Devenir , approximately 13.8 million Americans have ...
(Date:7/7/2015)... Antonio, TX (PRWEB) , ... July 07, 2015 , ... ... has once again teamed up with Soldiers’ Angels and announced a new charity campaign ... is the motivation and mission of Soldiers’ Angels, which was created especially to care ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... today announced that TimberNook ( http://www.timbernook.com/ ) has selected the agency ... and marketing launch package for new camp providers. TimberNook is a nature-based ...
Breaking Medicine News(10 mins):Health News:Dr. Pedro S. Alupay, M.D., Now Providing Pain Management Services at Healthpointe in Irwindale 2Health News:Dr. Pedro S. Alupay, M.D., Now Providing Pain Management Services at Healthpointe in Irwindale 3Health News:A Forever Recovery Releases New Information on “Club Drugs” and Tips for Parents of Teens and Young Adults 2Health News:Introducing HSAstore.com: A New E-commerce Site for Health Savings Account Eligible Products and Services 2Health News:Introducing HSAstore.com: A New E-commerce Site for Health Savings Account Eligible Products and Services 3Health News:Clear Insurance Group and Nonprofit Soldiers’ Angels Initiate New Charity Campaign in San Antonio, TX to Provide Aid and Comfort for Veterans 2Health News:Clear Insurance Group and Nonprofit Soldiers’ Angels Initiate New Charity Campaign in San Antonio, TX to Provide Aid and Comfort for Veterans 3Health News:TimberNook Selects Calypso Communications for PR, Social Media and Content Strategy 2
... as it is, is a very popular drink in Europe and ... have manufactured a healthy beer called karla //, which they claim ... ,The beer is made form herbs and also contains ... with a lower alcohol percentage. Chemists claim that the sale of ...
... the UT Southwestern Medical Center have found that brain ... them training using robotic treadmill. This is believed to ... paralysis following spinal cord injury. ,In the ... injured persons are capable of activating areas of brain ...
... study that women tend to take their heart disease in a ... finding could account for less number of women // who turn ... the single most killer of both women and men. ... for a heart attack or severe chest pain. The women under ...
... 5 people have lost their lives in Pakistan due to ... fever.// Another 40 people are reported to have been infected ... Crimean-Congo hemorrhagic fever (CCHF) are dead, including a lady doctor, ... hospitals,' a spokesman of the Health Ministry said. All the ...
... at Chapel Hill have discovered a molecule that triggers ... part of the tyrosine kinase gene family and triggers ... signals and directing cells to dump a tumor-suppressor protein. ... that the cell destroy itself. Researchers say that Ack1 ...
... producer of mug bean sprouts had to stop production due ... issued an order today against Toronto Sun Wah Trading Inc. ... product may be contaminated with Salmonella. ,Two hundred and ... of Health and Long-Term Care from across the province. The ...
Cached Medicine News:Health News:Paralyzed Patients Can Be Trained To Walk With Robotic Treadmill 2Health News:Are Women Not Hearty Enough Towards Seeking Heart Care? 2Health News:Dengue Fever Claims Five Lives In Pakistan 2
... Titer Performance Panel consists of plasma specimens ... positive for antibodies to HTLV I and ... by manufacturers and diagnostic laboratories to evaluate ... all major test systems are included for ...
... Avaulta™ BioSynthetic Mesh is ... coated in the central ... hydrophilic film of porcine ... of the Avaulta™ BioSynthetic ...
Suspend® Tutoplast® Processed Fascia Lata is your naturally safe and strong choice for pelvic floor reconstruction. Suspend comes from a dense matrix of collagen bundles and transverse fasc...
... Bard® Dermal Allograft ... of most pelvic floor ... highly resistant to suture ... and serves as a ...
Medicine Products: